Cargando…
Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent chronic liver disorders worldwide. It is closely associated with metabolic syndrome components, including type 2 diabetes, hyperlipidaemia and obesity. To date, no effective drug treatment is available for NAFLD but several clinic...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108664/ https://www.ncbi.nlm.nih.gov/pubmed/37077770 http://dx.doi.org/10.7573/dic.2023-1-4 |